Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingling Shan

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Hematology & Oncology|April 5, 2023
Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemiaYue Tan, Lingling Shan, Liping Zhao, et al.
Blood|July 25, 2025
Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trialJing Pan, Liping Zhao, Yibing Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 27, 2019
Exceedingly Small Gadolinium Oxide Nanoparticles with Remarkable Relaxivities for Magnetic Resonance Imaging of TumorsZheyu Shen, Wenpei Fan, Zhen Yang, et al.
Nature Medicine|October 1, 2024
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trialJing Pan, Yue Tan, Lingling Shan, et al.
Nature Medicine|October 16, 2024
Publisher Correction: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trialJing Pan, Yue Tan, Lingling Shan, et al.
Nature Communications|March 20, 2019
Generic synthesis of small-sized hollow mesoporous organosilica nanoparticles for oxygen-independent X-ray-activated synergistic therapyWenpei Fan, Nan Lu, Zheyu Shen, et al.
Nature Communications|February 16, 2026
Author Correction: Generic synthesis of small-sized hollow mesoporous organosilica nanoparticles for oxygen-independent X-ray-activated synergistic therapyWenpei Fan, Nan Lu, Zheyu Shen, et al.
Nature Communications|July 22, 2024
C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trialShiyu Zuo, Chuo Li, Xiaolei Sun, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Hematology & Oncology|April 5, 2023
Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemiaYue Tan, Lingling Shan, Liping Zhao, et al.
Blood|July 25, 2025
Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trialJing Pan, Liping Zhao, Yibing Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 27, 2019
Exceedingly Small Gadolinium Oxide Nanoparticles with Remarkable Relaxivities for Magnetic Resonance Imaging of TumorsZheyu Shen, Wenpei Fan, Zhen Yang, et al.
Nature Medicine|October 1, 2024
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trialJing Pan, Yue Tan, Lingling Shan, et al.
Nature Medicine|October 16, 2024
Publisher Correction: Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trialJing Pan, Yue Tan, Lingling Shan, et al.
Nature Communications|March 20, 2019
Generic synthesis of small-sized hollow mesoporous organosilica nanoparticles for oxygen-independent X-ray-activated synergistic therapyWenpei Fan, Nan Lu, Zheyu Shen, et al.
Nature Communications|February 16, 2026
Author Correction: Generic synthesis of small-sized hollow mesoporous organosilica nanoparticles for oxygen-independent X-ray-activated synergistic therapyWenpei Fan, Nan Lu, Zheyu Shen, et al.
Nature Communications|July 22, 2024
C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trialShiyu Zuo, Chuo Li, Xiaolei Sun, et al.
Pageof 5